Navigation Links
AMDL Receives a Significant Updated Appraisal of Its JJB China Production Facilities
Date:2/4/2008

TUSTIN, Calif., Feb. 4 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi, and Jilin, China, through its wholly owned subsidiary Jade Pharmaceutical Inc. (JPI), is an international biopharma company that, together with Jade, engages in the development, manufacture and marketing of proprietary pharmaceutical, health care and diagnostic products. The Company announced today that JPI's subsidiary JJB received an updated third party valuation of its land use rights, plant and buildings that have been now been reappraised for a total of approximately $21.8 million, significantly above the FY2007 book value of these assets.

Frank Zheng, Managing Director of Jade, stated that "This new appraisal by the accounting firm of Jiangxi Zhong Cheng Accounting Co., Ltd., is anticipated to provide JJB with the ability to significantly expand its current credit facilities, including gaining larger credit facilities under more favorable interest rates."

Mr. Gary Dreher, CEO of AMDL noted that "this new appraisal is another illustration of the significant value that JPI's business brings to AMDL in 2008 and beyond."

About Jade Pharmaceutical Inc.: Jade has access to the fastest growing pharmaceutical and consumer market in the world: China. AMDL, through its subsidiaries, Jade currently manufactures large volume injection fluids, tablets and other related products, holding licenses for 133 products. It also manufactures 107 generic, over the counter and supplemental pharmaceutical products under certified Chinese Good Manufacturing Practice (CGMP) standards.

About AMDL: More information about AMDL and its products can be obtained at http://www.amdl.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statem
'/>"/>

SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
5. IsoTis Receives FDA Clearance for Accell Family of Products
6. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
7. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
8. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
9. XTL Receives Staff Letter From NASDAQ
10. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
11. Hemo-Stream(TM) Chronic Dialysis Catheter Receives FDA Clearance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2014)... the University of Illinois at Urbana-Champaign have demonstrated ... (pBNAs) can be used like traditional photographic film ... smaller than the wavelength of light (for example, ... A standard optical microscope acts as a "nanocamera" ... "Unlike conventional photographic film, the effect (writing and ...
(Date:7/18/2014)... 18, 2014 Emerging Nuclear Power Countries ... 2030 , Summary , The latest report from GlobalData, ... and Development Analysis to 2030 covers the emerging nuclear ... provides comprehensive information on key market players and their ... in various countries across the world has also been ...
(Date:7/17/2014)... WASHINGTON , July 17, 2014  Vanda Pharmaceuticals ... company focused on the development and commercialization of products ... announced it will release results for the second quarter ... market opens. The Company will host ... August 7, 2014, during which Vanda management will discuss ...
(Date:7/17/2014)... major road blocks to the design and development of ... Researchers with the Lawrence Berkeley National Laboratory (Berkeley Lab) ... meaning a theoretical model free of adjustable or ... carriers" in semiconductors. Hot carriers are electrical charge carriers ... than charge carriers at thermal equilibrium. , "Hot carrier ...
Breaking Biology Technology:'Nanocamera' takes pictures at distances smaller than light's own wavelength 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 3Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014 2First ab initio method for characterizing hot carriers 2First ab initio method for characterizing hot carriers 3
... Aureus Pharma, a leading provider of,knowledge management ... release today of the new software solution ... evaluate target, cell and,drug profiles using bio-assays ... Pharma,s AurSCOPE Target Knowledge databases. AurPROFILER has ...
... Inc., the,operating company of WuXi PharmaTech (NYSE: ... of Garry Takle, Ph.D. as Vice President of ... Testing Services for its,Philadelphia facility., (Logo: ... with the company for nine years in roles ...
... HILL, N.C., Aug. 15 The U.S. ... into multiple market,segments. In this challenging marketplace, ... complex organizational and,decision-making structures to effectively represent ... being influenced by medical professionals,focused on efficacy ...
Cached Biology Technology:Aureus Pharma Releases AurPROFILER(R) - a New and Powerful Pharmacology Profiling Solution 2WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility 2U.S. Hospital Sales Opportunities Maximized Through Functional Optimization 2
(Date:7/21/2014)... developed a pioneering new way using samples of ... of drugs on the heart without using human or ... Dr Helen Maddock an expert in cardiovascular physiology ... and Exercise Sciences and could lead to the ... the quality of their treatments improved. , Adverse effects ...
(Date:7/21/2014)... Boston, MA Scientists at Brigham and Women,s Hospital ... generate fully functional human platelets in vitro. The work ... blood transfusion needs worldwide. , The study is published ... "The ability to generate an alternative source of functional ... paradigm shift in how we collect platelets that may ...
(Date:7/21/2014)... July 21, 2014 Research and Markets ( ... "Next Generation Biometric Market by Technology, Function, ... 2014 - 2020" report to their offering. ... is the verification of humans by their characteristics ... vein, and DNA. DNA and vein recognition are ...
Breaking Biology News(10 mins):New technique uses 'simulated' human heart to screen drugs 2Scientists successfully generate human platelets using next-generation bioreactor 2Global Next Generation Biometric Market by Technology, Function, Application & by Geography - Forecasts & Analysis to 2020 2Global Next Generation Biometric Market by Technology, Function, Application & by Geography - Forecasts & Analysis to 2020 3
... reef, the Scken reef in the Koster Fjord, is ... the University of Gothenburg have started a restoration project ... being removed and placed on the Scken reef. ... In Sweden, only one reef-building coral species exists, a ...
... prone to extinction than others? A new study of marine ... million years of fossil data for marine invertebrates reveals that ... hit even when populations are large, the authors report. ... surface. But because monitoring data are harder to collect at ...
... -- Buffalo Grove, Illinois-based specialty-oncology drug development company, Meridian ... Food and Drug Administration (FDA) has granted Meridian,s ... (pre-IND) meeting to discuss its plan to commence ... various cancer indications. The meeting is scheduled for ...
Cached Biology News:Sweden's only coral reef at risk of dying 2Sweden's only coral reef at risk of dying 3Fossil study helps pinpoint extinction risks for ocean animals 2FDA Grants Meridian Laboratories Pre-Ind Meeting for Captisol-Enabled Docetaxel in the Treatment of Cancer 2
... omental preadipocytes are isolated ... healthy donors. There is ... cells. Please inquire for ... also available. Academic discounts ...
Anti-Flavocytochrome b Monoclonal, FITC Labeled Research Focus: other Storage: 4C Shipping Temperature: 4C...
Yields DNA greater than 50 kb in length from yeast, fungi, Gram neg. and Gram pos. bacteria...
Goat polyclonal to ORC2L ( Abpromise for all tested applications). entrezGeneID: 4999 SwissProtID: Q13416...
Biology Products: